Floatz logo

Doxycycline

Endometrial Serous Adenocarcinoma

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversitySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Endometrial Serous Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
National Cancer Institute (NCI)
Phase 3BB
Temsirolimus
National Cancer Institute (NCI)
Phase 2B
Cediranib
National Cancer Institute (NCI)
Phase 2B
Bms-907351
National Cancer Institute (NCI)
Phase 2B
Pembrolizumab
Roswell Park Cancer Institute
Phase 2CCC

View all 22 →

Same molecule, other indications

Doxycycline is also rated in:

lymphangioleiomyomatosisDormant
BB
Indicative ·
64 / 100
View asset →
tuberous sclerosisDormant
BB
Indicative ·
64 / 100
View asset →
Chronic Pelvic Pain SyndromeDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →